医
China Med Service
Best doctors, yours
Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties
Plaque parapsoriasis (L41.801) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Other parapsoriasis (L41.800) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Reticular parapsoriasis (L41.500) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Large-plaque parapsoriasis (L41.400) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Small-plaque parapsoriasis (L41.300) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Lymphomatoid papulosis is chronic recurrent self-healing papulonecrotic eruption (CD30+ lymphoproliferative); topical steroids, phototherapy, methotrexate, monitor for association with cutaneous ALCL/mycosis fungoides.
皮肤科Chronic lichenoid pityriasis (L41.100) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Mucha-Habermann disease (L41.001) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Acute febrile necrotic-ulcerative pityriasis lichenoides (L41.000x002) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological intro
PLEVA (L41.000x001) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Pityriasis lichenoides et varioliformis acuta (PLEVA) (L41.000) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction
Psoriasis is chronic immune-mediated hyperproliferative dermatosis; topical steroids/vitamin-D analogs, phototherapy, methotrexate/cyclosporine, biologics (TNF/IL-17/IL-23), avoid triggers, monitor comorbidities.
皮肤科Erythrodermic psoriasis (L40.802) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Inverse psoriasis (L40.801) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Diaper psoriasis (L40.800x004) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Psoriatic nephritis (L40.800x002) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Other psoriasis (L40.800) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Psoriatic juvenile arthritis () is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Psoriatic arthritis is spondyloarthritis linked to psoriasis; NSAIDs, DMARDs (methotrexate/leflunomide), biologics (TNF/IL-17/IL-23 inhibitors), topical skin therapy, monitor joint damage.
皮肤科Psoriatic arthritis (L40.500x001) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
|
